Ronnie Cutler
@cutleraging
PhD candidate studying the role of somatic mutations in human aging with Vijg & Sidoli Labs @EinsteinMed
ID: 1002720796060643333
02-06-2018 01:17:22
2,2K Tweet
447 Followers
836 Following
AbbVie is acquiring YC S20 alum Gilgamesh Pharma’s psychedelic drug bretisilocin for up to $1.2B after it showed a 94% remission rate in Phase 2 trials for major depressive disorder. A big step toward new treatments in psychiatry. Congrats to the team! fiercebiotech.com/biotech/abbvie…
Excited for a major milestone in a collab effort led by Jesse Engreitz to map enhancers & interpret variants in the human genome: The E2G Portal e2g.stanford.edu collates predictions of enhancer-gene regulatory interactions across >1,600 cell types & tissues. Use cases 👇1/
As requested by the toiling intellectual masses, together with Jan Gruber, we've just put up a theory summary. Enjoy some excerpts + the link in the first comment. Complex systems are built hierarchically: at each scale, new variables and patterns emerge from the collective